Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Community Research Initiative, New York

Chelsea Village Med Ctr, New York

Mem Sloan - Kettering Cancer Ctr, New York

Long Island Jewish Med Ctr, New Hyde Park

Brooklyn Veterans Administration, Brooklyn

Maimonides Med Ctr, Brooklyn

Nassau County Med Ctr, East Meadow

Veterans Administration Med Ctr, Washington D.C.

Johns Hopkins School of Medicine, Baltimore

Dr Winkler Weinberg, Roswell

AIDS Research Consortium of Atlanta, Atlanta

Grady Memorial Hosp / Hughs Spalding Med Ctr, Atlanta

VP Med Services / HHCS Research Institute Inc, Orlando

Mem Hosp Hollywood, Hollywood

Ctr for Special Immunology, Fort Lauderdale

TheraFirst Med Ctrs Inc, Fort Lauderdale

Ohio State Univ Med Ctr, Columbus

Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland

Univ of Missouri at Kansas City School of Medicine, Kansas City

Research Med Ctr, Kansas City

Nelson Tebedo Community Clinic, Dallas

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

Scott and White Hosp, Temple

Dr Scott Lea, Waco

Baylor College of Medicine, Houston

Houston Clinical Research Network, Houston

Univ TX San Antonio Health Science Ctr, San Antonio

Central Texas Med Foundation, Austin

Texas Tech Health Sciences Ctr, El Paso

Denver Public Health Dept, Denver

Olive View Med Ctr, Sylmar

Ctr for Special Immunology, Irvine

CRI of New England, Brookline